secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0000950170-24-075603
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical stockholders elect all three director nominees, approve say-on-pay, ratify E&Y
--------------------------------------------------------------------------------

- Directors Croarkin, Humphries, and Hutson elected with ~30M votes for each; no nominee withheld.
- Advisory vote on executive compensation approved: 22.8M for, 5.2M against, 6.6M abstentions.
- Ratification of Ernst & Young as independent auditor for FY2024 passed: 45.1M for, 4.9M against.
- Total shares present at meeting: 50.1M (67% of 74.7M outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/0000950170-24-075603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/clsd-20240620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-075603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer